Kirsten J. Moffat

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Cardiovascular magnetic resonance feature tracking for rejection surveillance after cardiac transplantation.

Cardiovascular magnetic resonance feature tracking for rejection surveillance after cardiac transplantation.

Journal: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance

Published: July 10, 2025

Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation.

Cardiovascular Magnetic Resonance for Rejection Surveillance After Cardiac Transplantation.

Journal: Circulation

Published: May 27, 2022

Everolimus for the Prevention of Calcineurin-Inhibitor-Induced Left Ventricular Hypertrophy After Heart Transplantation (RADTAC Study).

Everolimus for the Prevention of Calcineurin-Inhibitor-Induced Left Ventricular Hypertrophy After Heart Transplantation (RADTAC Study).

Journal: JACC. Heart failure

Published: September 04, 2020

Imaging correlates of the blood-brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications.

Imaging correlates of the blood-brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications.

Journal: AIDS (London, England)

Published: July 06, 2019

Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection.

Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection.

Journal: AIDS (London, England)

Published: October 17, 2018

Native T1 Mapping in the Diagnosis of Cardiac Allograft Rejection: A Prospective Histologically Validated Study.

Native T1 Mapping in the Diagnosis of Cardiac Allograft Rejection: A Prospective Histologically Validated Study.

Journal: JACC. Cardiovascular imaging

Published: September 21, 2017

Erratum to: White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration.

Erratum to: White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration.

Journal: Journal of neurovirology

Published: July 30, 2017

Covertly active and progressing neurochemical abnormalities in suppressed HIV infection.

Covertly active and progressing neurochemical abnormalities in suppressed HIV infection.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 23, 2017

White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration.

White matter measures are near normal in controlled HIV infection except in those with cognitive impairment and longer HIV duration.

Journal: Journal of neurovirology

Published: November 28, 2016

Functional Connectivity in Virally Suppressed Patients with HIV-Associated Neurocognitive Disorder: A Resting-State Analysis.

Functional Connectivity in Virally Suppressed Patients with HIV-Associated Neurocognitive Disorder: A Resting-State Analysis.

Journal: AJNR. American journal of neuroradiology

Published: July 11, 2016

Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder.

Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder.

Journal: AIDS (London, England)

Published: January 31, 2016

HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study.

HIV, vascular and aging injuries in the brain of clinically stable HIV-infected adults: a (1)H MRS study.

Journal: PloS one

Published: August 14, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026